0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Blood Vessel Market Research Report 2026
Published Date: 2026-01-15
|
Report Code: QYRE-Auto-37E4144
Home | Market Reports | Health| Medical Devices & Equipment
Global Artificial Blood Vessel Market Research Report 2021
BUY CHAPTERS

Global Artificial Blood Vessel Market Research Report 2026

Code: QYRE-Auto-37E4144
Report
2026-01-15
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artificial Blood Vessel Market Size

The global Artificial Blood Vessel market was valued at US$ 3938 million in 2025 and is anticipated to reach US$ 4927 million by 2032, at a CAGR of 3.3% from 2026 to 2032.

Artificial Blood Vessel Market

Artificial Blood Vessel Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Artificial Blood Vessel competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover. The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it’s a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g. collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better.
Expanding Market Size
With continuous advancements in medical technology and intensifying population aging, the market size for artificial blood vessels in China is also expanding steadily. It is estimated that the growth rate of the Chinese market will exceed the global average in the coming years.
Technological Innovation Driving Market Development
Application of New Materials: The field of artificial blood vessels is moving towards the direction of biodegradability, enhanced biocompatibility, and superior biomechanical properties. The application of biodegradable materials such as polylactic acid (PLA) and polycaprolactone (PCL) is expected to reduce the risks associated with long-term implantation in the body and improve patients' quality of life. The integration of nanotechnology has also brought new opportunities for enhancing the performance of artificial blood vessels. The application of nano-coatings and nano-fibers can enhance the blood vessels' antithrombotic capabilities, antibacterial properties, and durability, making artificial blood vessels safer and more reliable in clinical applications.
Advancements in Bioprinting Technology: Bioprinting allows for the manufacturing of artificial blood vessels with complex structures and functions, better matching the physiological characteristics of human blood vessels, thus improving surgical success rates and patients' recovery speeds. Additionally, bioprinting technology enables the customization of artificial blood vessels to meet the diverse needs of different patients and surgical procedures.
Intensifying Competition and Rising Market Concentration
Competition Among Domestic and Foreign Enterprises: With the entrance of both domestic and foreign enterprises, competition in the artificial blood vessel market is becoming increasingly fierce. Companies need to continuously reduce costs to maintain their competitiveness while increasing investments in innovation and research and development to create differentiated advantages.
Rising Market Concentration: The concentration of the Chinese artificial blood vessel market is relatively high, with major market participants occupying a significant market share. This concentration is reflected in diverse product lines, strong brand influence, and extensive market coverage. In the future, with intensifying market competition and industry consolidation, market concentration is expected to further increase.
Policies and Health Insurance Support Promoting Market Development
Policy Support: Government departments such as the National Development and Reform Commission have increased investments in medical services, promoting healthy capital flows for enterprises through policy support and accelerating industry development.
Health Insurance Coverage: The improvement of the health insurance system has made artificial blood vessel treatments more affordable for more patients, further driving the growth of market demand. In the future, with the expansion of health insurance coverage and optimization of reimbursement policies, the demand for artificial blood vessels is expected to further increase.
This report delivers a comprehensive overview of the global Artificial Blood Vessel market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artificial Blood Vessel. The Artificial Blood Vessel market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Artificial Blood Vessel market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Artificial Blood Vessel manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Artificial Blood Vessel Market Report

Report Metric Details
Report Name Artificial Blood Vessel Market
Accounted market size in 2025 US$ 3938 million
Forecasted market size in 2032 US$ 4927 million
CAGR 3.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • EPTFE
  • Polyethylene Terephthalate
  • Polyurethane
  • Others
by Application
  • Aortic Disease
  • Peripheral Artery Disease
  • Hemodialysis
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Getinge, Bard PV, Terumo, W. L. Gore, Japan Lifeline, B.Braun, LeMaitre Vascular, Shanghai Chest Medical Instruments, Aortec Medical Technology, JIANGSU BIODA LIFE SCIENCE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Artificial Blood Vessel manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Artificial Blood Vessel sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Artificial Blood Vessel Market growing?

Ans: The Artificial Blood Vessel Market witnessing a CAGR of 3.3% during the forecast period 2026-2032.

What is the Artificial Blood Vessel Market size in 2032?

Ans: The Artificial Blood Vessel Market size in 2032 will be US$ 4927 million.

Who are the main players in the Artificial Blood Vessel Market report?

Ans: The main players in the Artificial Blood Vessel Market are Getinge, Bard PV, Terumo, W. L. Gore, Japan Lifeline, B.Braun, LeMaitre Vascular, Shanghai Chest Medical Instruments, Aortec Medical Technology, JIANGSU BIODA LIFE SCIENCE

What are the Application segmentation covered in the Artificial Blood Vessel Market report?

Ans: The Applications covered in the Artificial Blood Vessel Market report are Aortic Disease, Peripheral Artery Disease, Hemodialysis

What are the Type segmentation covered in the Artificial Blood Vessel Market report?

Ans: The Types covered in the Artificial Blood Vessel Market report are EPTFE, Polyethylene Terephthalate, Polyurethane, Others

1 Artificial Blood Vessel Market Overview
1.1 Product Definition
1.2 Artificial Blood Vessel by Type
1.2.1 Global Artificial Blood Vessel Market Value by Type: 2025 vs 2032
1.2.2 EPTFE
1.2.3 Polyethylene Terephthalate
1.2.4 Polyurethane
1.2.5 Others
1.3 Artificial Blood Vessel by Application
1.3.1 Global Artificial Blood Vessel Market Value by Application: 2025 vs 2032
1.3.2 Aortic Disease
1.3.3 Peripheral Artery Disease
1.3.4 Hemodialysis
1.4 Global Artificial Blood Vessel Market Size Estimates and Forecasts
1.4.1 Global Artificial Blood Vessel Revenue 2021–2032
1.4.2 Global Artificial Blood Vessel Sales 2021–2032
1.4.3 Global Artificial Blood Vessel Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Artificial Blood Vessel Market Competition by Manufacturers
2.1 Global Artificial Blood Vessel Sales Market Share by Manufacturers (2021–2026)
2.2 Global Artificial Blood Vessel Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Artificial Blood Vessel Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Artificial Blood Vessel, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Artificial Blood Vessel, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Artificial Blood Vessel, Product Types and Applications
2.7 Global Key Manufacturers of Artificial Blood Vessel, Date of Entry into the Industry
2.8 Global Artificial Blood Vessel Market Competitive Situation and Trends
2.8.1 Global Artificial Blood Vessel Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Artificial Blood Vessel Players Market Share by Revenue
2.8.3 Global Artificial Blood Vessel Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Artificial Blood Vessel Market Scenario by Region
3.1 Global Artificial Blood Vessel Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Artificial Blood Vessel Sales by Region: 2021–2032
3.2.1 Global Artificial Blood Vessel Sales by Region: 2021–2026
3.2.2 Global Artificial Blood Vessel Sales by Region: 2027–2032
3.3 Global Artificial Blood Vessel Revenue by Region: 2021–2032
3.3.1 Global Artificial Blood Vessel Revenue by Region: 2021–2026
3.3.2 Global Artificial Blood Vessel Revenue by Region: 2027–2032
3.4 North America Artificial Blood Vessel Market Facts & Figures by Country
3.4.1 North America Artificial Blood Vessel Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Artificial Blood Vessel Sales by Country (2021–2032)
3.4.3 North America Artificial Blood Vessel Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Blood Vessel Market Facts & Figures by Country
3.5.1 Europe Artificial Blood Vessel Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Artificial Blood Vessel Sales by Country (2021–2032)
3.5.3 Europe Artificial Blood Vessel Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Blood Vessel Market Facts & Figures by Region
3.6.1 Asia Pacific Artificial Blood Vessel Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Artificial Blood Vessel Sales by Region (2021–2032)
3.6.3 Asia Pacific Artificial Blood Vessel Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artificial Blood Vessel Market Facts & Figures by Country
3.7.1 Latin America Artificial Blood Vessel Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Artificial Blood Vessel Sales by Country (2021–2032)
3.7.3 Latin America Artificial Blood Vessel Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Blood Vessel Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Blood Vessel Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Artificial Blood Vessel Sales by Country (2021–2032)
3.8.3 Middle East and Africa Artificial Blood Vessel Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Artificial Blood Vessel Sales by Type (2021–2032)
4.1.1 Global Artificial Blood Vessel Sales by Type (2021–2026)
4.1.2 Global Artificial Blood Vessel Sales by Type (2027–2032)
4.1.3 Global Artificial Blood Vessel Sales Market Share by Type (2021–2032)
4.2 Global Artificial Blood Vessel Revenue by Type (2021–2032)
4.2.1 Global Artificial Blood Vessel Revenue by Type (2021–2026)
4.2.2 Global Artificial Blood Vessel Revenue by Type (2027–2032)
4.2.3 Global Artificial Blood Vessel Revenue Market Share by Type (2021–2032)
4.3 Global Artificial Blood Vessel Price by Type (2021–2032)
5 Segment by Application
5.1 Global Artificial Blood Vessel Sales by Application (2021–2032)
5.1.1 Global Artificial Blood Vessel Sales by Application (2021–2026)
5.1.2 Global Artificial Blood Vessel Sales by Application (2027–2032)
5.1.3 Global Artificial Blood Vessel Sales Market Share by Application (2021–2032)
5.2 Global Artificial Blood Vessel Revenue by Application (2021–2032)
5.2.1 Global Artificial Blood Vessel Revenue by Application (2021–2026)
5.2.2 Global Artificial Blood Vessel Revenue by Application (2027–2032)
5.2.3 Global Artificial Blood Vessel Revenue Market Share by Application (2021–2032)
5.3 Global Artificial Blood Vessel Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Getinge
6.1.1 Getinge Company Information
6.1.2 Getinge Description and Business Overview
6.1.3 Getinge Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Getinge Artificial Blood Vessel Product Portfolio
6.1.5 Getinge Recent Developments/Updates
6.2 Bard PV
6.2.1 Bard PV Company Information
6.2.2 Bard PV Description and Business Overview
6.2.3 Bard PV Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bard PV Artificial Blood Vessel Product Portfolio
6.2.5 Bard PV Recent Developments/Updates
6.3 Terumo
6.3.1 Terumo Company Information
6.3.2 Terumo Description and Business Overview
6.3.3 Terumo Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Terumo Artificial Blood Vessel Product Portfolio
6.3.5 Terumo Recent Developments/Updates
6.4 W. L. Gore
6.4.1 W. L. Gore Company Information
6.4.2 W. L. Gore Description and Business Overview
6.4.3 W. L. Gore Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 W. L. Gore Artificial Blood Vessel Product Portfolio
6.4.5 W. L. Gore Recent Developments/Updates
6.5 Japan Lifeline
6.5.1 Japan Lifeline Company Information
6.5.2 Japan Lifeline Description and Business Overview
6.5.3 Japan Lifeline Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Japan Lifeline Artificial Blood Vessel Product Portfolio
6.5.5 Japan Lifeline Recent Developments/Updates
6.6 B.Braun
6.6.1 B.Braun Company Information
6.6.2 B.Braun Description and Business Overview
6.6.3 B.Braun Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 B.Braun Artificial Blood Vessel Product Portfolio
6.6.5 B.Braun Recent Developments/Updates
6.7 LeMaitre Vascular
6.7.1 LeMaitre Vascular Company Information
6.7.2 LeMaitre Vascular Description and Business Overview
6.7.3 LeMaitre Vascular Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 LeMaitre Vascular Artificial Blood Vessel Product Portfolio
6.7.5 LeMaitre Vascular Recent Developments/Updates
6.8 Shanghai Chest Medical Instruments
6.8.1 Shanghai Chest Medical Instruments Company Information
6.8.2 Shanghai Chest Medical Instruments Description and Business Overview
6.8.3 Shanghai Chest Medical Instruments Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Shanghai Chest Medical Instruments Artificial Blood Vessel Product Portfolio
6.8.5 Shanghai Chest Medical Instruments Recent Developments/Updates
6.9 Aortec Medical Technology
6.9.1 Aortec Medical Technology Company Information
6.9.2 Aortec Medical Technology Description and Business Overview
6.9.3 Aortec Medical Technology Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Aortec Medical Technology Artificial Blood Vessel Product Portfolio
6.9.5 Aortec Medical Technology Recent Developments/Updates
6.10 JIANGSU BIODA LIFE SCIENCE
6.10.1 JIANGSU BIODA LIFE SCIENCE Company Information
6.10.2 JIANGSU BIODA LIFE SCIENCE Description and Business Overview
6.10.3 JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Product Portfolio
6.10.5 JIANGSU BIODA LIFE SCIENCE Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Blood Vessel Industry Chain Analysis
7.2 Artificial Blood Vessel Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Blood Vessel Production Mode & Process Analysis
7.4 Artificial Blood Vessel Sales and Marketing
7.4.1 Artificial Blood Vessel Sales Channels
7.4.2 Artificial Blood Vessel Distributors
7.5 Artificial Blood Vessel Customer Analysis
8 Artificial Blood Vessel Market Dynamics
8.1 Artificial Blood Vessel Industry Trends
8.2 Artificial Blood Vessel Market Drivers
8.3 Artificial Blood Vessel Market Challenges
8.4 Artificial Blood Vessel Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Artificial Blood Vessel Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Artificial Blood Vessel Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Artificial Blood Vessel Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Artificial Blood Vessel Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Artificial Blood Vessel Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Artificial Blood Vessel Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Artificial Blood Vessel Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Artificial Blood Vessel Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Artificial Blood Vessel, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Artificial Blood Vessel, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Artificial Blood Vessel, Product Types and Applications
 Table 12. Global Key Manufacturers of Artificial Blood Vessel, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Artificial Blood Vessel Companies by Tier (Tier 1, Tier 2, Tier 3), based on Artificial Blood Vessel Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Artificial Blood Vessel Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Artificial Blood Vessel Sales by Region (K Units), 2021–2026
 Table 18. Global Artificial Blood Vessel Sales Market Share by Region (2021–2026)
 Table 19. Global Artificial Blood Vessel Sales by Region (K Units), 2027–2032
 Table 20. Global Artificial Blood Vessel Sales Market Share by Region (2027–2032)
 Table 21. Global Artificial Blood Vessel Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Artificial Blood Vessel Revenue Market Share by Region (2021–2026)
 Table 23. Global Artificial Blood Vessel Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Artificial Blood Vessel Revenue Market Share by Region (2027–2032)
 Table 25. North America Artificial Blood Vessel Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Artificial Blood Vessel Sales by Country (K Units), 2021–2026
 Table 27. North America Artificial Blood Vessel Sales by Country (K Units), 2027–2032
 Table 28. North America Artificial Blood Vessel Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Artificial Blood Vessel Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Artificial Blood Vessel Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Artificial Blood Vessel Sales by Country (K Units), 2021–2026
 Table 32. Europe Artificial Blood Vessel Sales by Country (K Units), 2027–2032
 Table 33. Europe Artificial Blood Vessel Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Artificial Blood Vessel Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Artificial Blood Vessel Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Artificial Blood Vessel Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Artificial Blood Vessel Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Artificial Blood Vessel Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Artificial Blood Vessel Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Artificial Blood Vessel Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Artificial Blood Vessel Sales by Country (K Units), 2021–2026
 Table 42. Latin America Artificial Blood Vessel Sales by Country (K Units), 2027–2032
 Table 43. Latin America Artificial Blood Vessel Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Artificial Blood Vessel Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Artificial Blood Vessel Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Artificial Blood Vessel Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Artificial Blood Vessel Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Artificial Blood Vessel Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Artificial Blood Vessel Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Artificial Blood Vessel Sales (K Units) by Type (2021–2026)
 Table 51. Global Artificial Blood Vessel Sales (K Units) by Type (2027–2032)
 Table 52. Global Artificial Blood Vessel Sales Market Share by Type (2021–2026)
 Table 53. Global Artificial Blood Vessel Sales Market Share by Type (2027–2032)
 Table 54. Global Artificial Blood Vessel Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Artificial Blood Vessel Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Artificial Blood Vessel Revenue Market Share by Type (2021–2026)
 Table 57. Global Artificial Blood Vessel Revenue Market Share by Type (2027–2032)
 Table 58. Global Artificial Blood Vessel Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Artificial Blood Vessel Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Artificial Blood Vessel Sales (K Units) by Application (2021–2026)
 Table 61. Global Artificial Blood Vessel Sales (K Units) by Application (2027–2032)
 Table 62. Global Artificial Blood Vessel Sales Market Share by Application (2021–2026)
 Table 63. Global Artificial Blood Vessel Sales Market Share by Application (2027–2032)
 Table 64. Global Artificial Blood Vessel Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Artificial Blood Vessel Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Artificial Blood Vessel Revenue Market Share by Application (2021–2026)
 Table 67. Global Artificial Blood Vessel Revenue Market Share by Application (2027–2032)
 Table 68. Global Artificial Blood Vessel Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Artificial Blood Vessel Price (USD/Unit) by Application (2027–2032)
 Table 70. Getinge Company Information
 Table 71. Getinge Description and Business Overview
 Table 72. Getinge Artificial Blood Vessel Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Getinge Artificial Blood Vessel Product
 Table 74. Getinge Recent Developments/Updates
 Table 75. Bard PV Company Information
 Table 76. Bard PV Description and Business Overview
 Table 77. Bard PV Artificial Blood Vessel Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Bard PV Artificial Blood Vessel Product
 Table 79. Bard PV Recent Developments/Updates
 Table 80. Terumo Company Information
 Table 81. Terumo Description and Business Overview
 Table 82. Terumo Artificial Blood Vessel Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Terumo Artificial Blood Vessel Product
 Table 84. Terumo Recent Developments/Updates
 Table 85. W. L. Gore Company Information
 Table 86. W. L. Gore Description and Business Overview
 Table 87. W. L. Gore Artificial Blood Vessel Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. W. L. Gore Artificial Blood Vessel Product
 Table 89. W. L. Gore Recent Developments/Updates
 Table 90. Japan Lifeline Company Information
 Table 91. Japan Lifeline Description and Business Overview
 Table 92. Japan Lifeline Artificial Blood Vessel Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Japan Lifeline Artificial Blood Vessel Product
 Table 94. Japan Lifeline Recent Developments/Updates
 Table 95. B.Braun Company Information
 Table 96. B.Braun Description and Business Overview
 Table 97. B.Braun Artificial Blood Vessel Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. B.Braun Artificial Blood Vessel Product
 Table 99. B.Braun Recent Developments/Updates
 Table 100. LeMaitre Vascular Company Information
 Table 101. LeMaitre Vascular Description and Business Overview
 Table 102. LeMaitre Vascular Artificial Blood Vessel Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. LeMaitre Vascular Artificial Blood Vessel Product
 Table 104. LeMaitre Vascular Recent Developments/Updates
 Table 105. Shanghai Chest Medical Instruments Company Information
 Table 106. Shanghai Chest Medical Instruments Description and Business Overview
 Table 107. Shanghai Chest Medical Instruments Artificial Blood Vessel Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Shanghai Chest Medical Instruments Artificial Blood Vessel Product
 Table 109. Shanghai Chest Medical Instruments Recent Developments/Updates
 Table 110. Aortec Medical Technology Company Information
 Table 111. Aortec Medical Technology Description and Business Overview
 Table 112. Aortec Medical Technology Artificial Blood Vessel Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Aortec Medical Technology Artificial Blood Vessel Product
 Table 114. Aortec Medical Technology Recent Developments/Updates
 Table 115. JIANGSU BIODA LIFE SCIENCE Company Information
 Table 116. JIANGSU BIODA LIFE SCIENCE Description and Business Overview
 Table 117. JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. JIANGSU BIODA LIFE SCIENCE Artificial Blood Vessel Product
 Table 119. JIANGSU BIODA LIFE SCIENCE Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Artificial Blood Vessel Distributors List
 Table 123. Artificial Blood Vessel Customers List
 Table 124. Artificial Blood Vessel Market Trends
 Table 125. Artificial Blood Vessel Market Drivers
 Table 126. Artificial Blood Vessel Market Challenges
 Table 127. Artificial Blood Vessel Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Artificial Blood Vessel
 Figure 2. Global Artificial Blood Vessel Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Artificial Blood Vessel Market Share by Type: 2025 & 2032
 Figure 4. EPTFE Product Picture
 Figure 5. Polyethylene Terephthalate Product Picture
 Figure 6. Polyurethane Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Artificial Blood Vessel Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Artificial Blood Vessel Market Share by Application: 2025 & 2032
 Figure 10. Aortic Disease
 Figure 11. Peripheral Artery Disease
 Figure 12. Hemodialysis
 Figure 13. Global Artificial Blood Vessel Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Artificial Blood Vessel Market Size (US$ Million), 2021–2032
 Figure 15. Global Artificial Blood Vessel Sales (K Units), 2021–2032
 Figure 16. Global Artificial Blood Vessel Average Price (USD/Unit), 2021–2032
 Figure 17. Artificial Blood Vessel Report Years Considered
 Figure 18. Artificial Blood Vessel Sales Share by Manufacturers in 2025
 Figure 19. Global Artificial Blood Vessel Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Artificial Blood Vessel Players: Market Share by Revenue in Artificial Blood Vessel in 2025
 Figure 21. Artificial Blood Vessel Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Artificial Blood Vessel Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Artificial Blood Vessel Sales Market Share by Country (2021–2032)
 Figure 24. North America Artificial Blood Vessel Revenue Market Share by Country (2021–2032)
 Figure 25. U.S. Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Artificial Blood Vessel Sales Market Share by Country (2021–2032)
 Figure 28. Europe Artificial Blood Vessel Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Artificial Blood Vessel Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Artificial Blood Vessel Revenue Market Share by Region (2021–2032)
 Figure 36. China Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Taiwan Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Indonesia Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Thailand Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Malaysia Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Philippines Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Artificial Blood Vessel Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Artificial Blood Vessel Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Artificial Blood Vessel Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Artificial Blood Vessel Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. U.A.E Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Artificial Blood Vessel by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Artificial Blood Vessel by Type (2021–2032)
 Figure 58. Global Artificial Blood Vessel Price (USD/Unit) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Artificial Blood Vessel by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Artificial Blood Vessel by Application (2021–2032)
 Figure 61. Global Artificial Blood Vessel Price (USD/Unit) by Application (2021–2032)
 Figure 62. Artificial Blood Vessel Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS